UK’s NICE recommends Pfizer’s rimegepant to treat migraine

The UK’s National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending the use of Pfizer’s …

USPTO grants Notice of Allowance for Tenax Therapeutics’ oral levosimendan

The US Patent and Trademark Office (USPTO) has granted a Notice of Allowance for Tenax Therapeutics’ patent application covering its …

New UK intracellular drug delivery centre to support RNA development

A new intracellular drug delivery centre will be established in the UK to support potential ribonucleic acid (RNA) vaccines and …

FDA approves Analog and Dipharma’s ANDA for nitisinone capsules

The US Food and Drug Administration (FDA) has granted clearance to Analog Pharma and Dipharma’s abbreviated new drug application (ANDA) …

(Cilnidipine + tadalafil) by AISA Pharma for Raynauds Disease: Likelihood of Approval

(Cilnidipine + tadalafil) is under clinical development by AISA Pharma and currently in Phase II for Raynauds Disease. According to …